Aptar Pharma continues its North American expansion
Aptar Pharma has acquired 20% of the US-based company, Kali Care, less than two months after inaugurating its first facility outside of France as it aims to expand globally.
Aptar Pharma has acquired 20% of the US-based company, Kali Care, less than two months after inaugurating its first facility outside of France as it aims to expand globally.
The full-service contract research organization (CRO) is moving to a new office in Boston, MA, which will serve at its fourth "hub," joining Berlin, Warsaw, and Kiev locations.
Clinical Research IO (CRIO) has developed a new “Lab Routing” module for its eSource system, which was purpose-built for clinical research sites.
Mergers and acquisitions remain a key growth strategy for contract manufacturing organizations (CMOs) as uncertainly persists across the industry.
President Donald Trump should foster biotech investment if he wants more US-made pharmaceuticals say experts who argue that cutting regulations to attract small molecule drug manufacturers will only have a limited effect.
Sanofi says it will demolish a pilot plant in Montpellier that has been left idle since its completion in 2011, citing its evolving biologics-focused portfolio.